InnovHeart (Newton, Massachusetts and Milan) announced the first trans-septal clinical trial implant of its proprietary Saturn transcatheter mitral valve. According to the company, there were excellent hemodynamic results for the patient — a 79-year-old woman suffering from severe mixed (degenerative and functional) mitral regurgitation. The … [Read more...] about InnovHeart has first in-human implantation of its TMVR